Stockscreener 앱 받기
6.43
0.47%
0.03
시간 외 거래:
6.43
전일 마감가:
$6.40
열려 있는:
$6.43
하루 거래량:
137.77K
Relative Volume:
0.59
시가총액:
$235.32M
수익:
$128.45M
순이익/손실:
$6.54M
주가수익비율:
-1.9367
EPS:
-3.32
순현금흐름:
$-8.79M
1주 성능:
-1.68%
1개월 성능:
+23.42%
6개월 성능:
+9.54%
1년 성능:
-12.99%
1일 변동 폭
$6.285
$6.49
1주일 범위
$6.285
$7.23
52주 변동 폭
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(612) 368-4300
주소
3515 LYMAN BLVD, CHASKA
LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| LFCR | 6.43 | 235.32M | 128.45M | 6.54M | -8.79M | -3.32 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Here’s Why Greenhaven Road Capital Invested in Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) biggest owners are individual investors who got richer after stock soared 14% last week - Simply Wall St
Lifecore Biomedical to Present at Stephens Annual Investment Conference - The Manila Times
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds - Yahoo Finance
Lifecore Biomedical: Finally A 'Pure Play' CDMO Business - Seeking Alpha
Trend Tracker for (LFCR) - Stock Traders Daily
Lifecore to host virtual investor day on November 21 - Nasdaq
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024 - GlobeNewswire
Lifecore Biomedical (LFCR) to Host Virtual Investor Day: Growth Strategy Unveiling | LFCR Stock News - StockTitan
Lifecore Biomedical (NASDAQ:LFCR) Trading Up 4.5%Time to Buy? - MarketBeat
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire
Lifecore Biomedical Makes Leadership Appointments - Contract Pharma
Chaska’s Lifecore looks to growth in coming years after emerging from delisting challenge - Star Tribune
How To Trade (LFCR) - Stock Traders Daily
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga
Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire
Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat
Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com
Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com
Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada
Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat
exhibit991-lfcrq1fy25ear.htm - SEC.gov
Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA
Lifecore Biomedical completes $24.3M private stock sale - Investing.com
Lifecore Biomedical completes $24.3M private stock sale By Investing.com - Investing.com Australia
Lifecore Raises Millions in Common Stock - Baystreet.ca
Lifecore Biomedical Raises $24.3M, Expands Capacity and Clientele - TipRanks
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical, Inc. Reports Earnings Results for the First Quarter Ended August 25, 2024 - Marketscreener.com
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - The Manila Times
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 - The Manila Times
Lifecore secures $5M deal with Lindy Biosciences for CDMO services By Investing.com - Investing.com South Africa
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):